Skip to main content
Fig. 3 | Thrombosis Journal

Fig. 3

From: Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis

Fig. 3

Probabilistic sensitivity analysis of the cost-effectiveness using Monte Carlo simulation over 6-month (left) and 5-year time horizon (right). The vertical axis represents incremental cost in USD, horizontal axis represents incremental effectiveness in QALYs, blue spots represents 1000 draws of the probabilistic analysis and the the slope of a line intersecting the origin of the plot represents the willingness to pay (WTP) limit. Values on the right side of the WTP line are considered cost-effective

Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us